Cowen analyst Tyler Van Buren reiterated an Outperform rating on Rocket Pharmaceuticals (NASDAQ: RCKT)The analyst comments "We caught up with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE